Began his career at Rhinolight as a sales manager in 2006, then promoted to become managing director in 2011. As a result of his over 11 years of work, the Turkish and Japanese markets were opened and registration in Australia was successfully achieved. Since 2015 mostly he has worked on the product introduction in some bigger Western European countries. Already a Ph.D. in pharmacy and he earned a degree in healthcare economics too. Dr. Dékány possesses a wide range of experience in professional marketing.E-mail Mobile: +36-70 452-2154
Member of the group inventing the Rhinolight therapy and device, a professional with a leading role in the technical development. Having worked for the company as a technical director since 2002, he is responsible for good manufacturing practice of Rhinolight devices and quality assurance. He currently works as a physicist university lecturer at the Department of Optics and Quantum Electronics at the University of Szeged.E-mail Mobile: +36-70 452-2264
Founding member of Rhinolight Ltd., its first investor and managing director back in 2004. He originated the creation of the Hungarian Rhinolight franchise system. In 2012, he rejoined the Rhinolight group as a strategic advisor managing partner. A successful healthcare and biotech investor, and majority owner of, among others, Goodwill Pharma Ltd. In addition to his general practicioner degree, he is a qualified otorhinolaryngologist.E-mail Mobile: +36-70 452-2255
Goodwill Pharma Group – a pharmaceutical company dealing with sales and production. Goodwill Pharma was the first investor to see an opportunity in the Rhinolight therapy, therefore the first clinical studies and devices manufactured in serial production were achieved with their help. Goodwill Pharma also initiated the launching of the franchise system, as well as the development of the instruments with a separate built-in counter.
Videoton Holding is the largest Hungarian industrial group in local private ownership offering manufacturing and related services for industrial firms. Serial production of the Rhinolight devices is provided by Videoton.
If you are interested in investing in Rhinolight, you have the chance to do so, as the company welcomes your ideas. We are primarily seeking strategic partners who could contribute to the global spreading of the therapy, or just simply want to be a part of an innovative therapeutic concept that might change your already existing ideas and habits regarding the treatment of allergy.